On February 21, Zang Jiandong, Chief of the General Division of the Research Office of the People's Government of Jiangsu Province, led a delegation to Sanpower for a survey on its current operation and future work idea, Yuan Yafei, Chairman of Sanpower, warmly received the delegation. Senior Vice President Yue Lei, Vice President of Public Relations Chen Xiaohua and Vice President of Senior Care Wang Haihong were present.

The delegation visited Sanpower’s corporate culture showroom, Brookstone concept store, and the Ageing Service Command Centre. After listening to an introduction to Sanpower's industrial layout and cross-border development, he marveled at its rapid development and wide business coverage.

At the meeting, Yuan introduced Sanpower's current development plan and overseas territory. In supply side reform, Sanpower will implement the plan in no time by acquiring outstanding enterprises to overtake its opponents, improving product quality to build its brand, and promoting consumption transformation and upgrading to create a new industrial highland.

Then Yue introduced Sanpower’s “broad health” industry. Through in-system resources, with big data analysis as orientation, and financial and insurance products as tools, Sanpower will operate in fields such as homecare and telemedicine. Last month, Sanpower signed to acquire Provenge, the first FDA-approved cellular immunotherapy against prostate cancer in the world, thereby moving into the front of global precision medicine. Last week, Sanpower announced that it had increased its investment in the general senior care service enterprise—Yi Le Ju, and introduced mature CCRC (Continuing Care Retirement Community) senior care model from the US. Sanpower also has medical business such as Xuzhou Third People’s Hospital.

After acquiring deeper knowledge of Sanpower, Zang acclaimed its fruitful results, spoke highly of its development strategy, and said that he would bring Sanpower’s experience back as the reference for policy research and formulation.